Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05409976 · ClinicalTrials.gov registry record · NA
The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study
A NA study of Venous Leg Ulcer and Venous Ulcer, sponsored by W.L.Gore & Associates.
- Active
- Registry status
- NA
- Development phase
- 112
- Enrollment target
- 17
- Study locations
NCT05409976 is a NA study of Venous Leg Ulcer and Venous Ulcer that is active but no longer recruiting, run by W.L.Gore & Associates. The registered enrollment target is 112 participants, below the 242-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (54% lower). The trial reports 17 study locations across 10 states.
The verdict
NCT05409976, a NA study of Venous Leg Ulcer and Venous Ulcer, is active but no longer recruiting, sponsored by W.L.Gore & Associates.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 112 participants
- Enrollment target
- 17
- Study locations
Study Summary
This study is a prospective, multicenter, non-randomized, single-arm study to evaluate the performance, safety, and efficacy of the GORE® VIABAHN® FORTEGRA Venous Stent (formerly known as GORE® VIAFORT Vascular Stent) for treatment of symptomatic inferior vena cava obstruction with or without combined iliofemoral obstruction in adult patients.
Conditions Studied
Interventions
- DEVICE GORE® VIAFORT Vascular Stent
Study Locations (17)
Other
- Universitätsklinikum Aachen - Aachen
- Alexianer Klinikum Hochsauerland GmbH - Arnsberg
- Ospedale San Raffaele - Milan
- Hesperia Hospital - Modena
- Auckland City Hospital - Auckland
- Addenbrooke's Hospital - Cambridge
- St Thomas' Hospital - London
New York
- Mount Sinai Medical Center - New York
- Weill Cornell Medical College - New York
California
- Stanford University School of Medicine - Stanford
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Illinois
- Northwestern - Chicago
Michigan
- University of Michigan - Ann Arbor
North Carolina
- Atrium Health-Sanger Heart and Vascular Institute - Charlotte
Virginia
- Sentara - Norfolk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2022-10-25 |
| Est. Completion | 2030-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05409976
The ClinicalTrials.gov registry entry for NCT05409976 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 242-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (54% lower). The listed sponsor is W.L.Gore & Associates, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Venous Leg Ulcer appearing as the primary indexed condition, and to 1 intervention - of which GORE® VIAFORT Vascular Stent is the first listed.
NCT05409976 reports 17 study locations spanning 10 distinct geographic areas - top geographies include Other, New York, California.
Frequently Asked Questions
What is clinical trial NCT05409976 about?
NCT05409976 is a clinical study titled "The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study". This study is a prospective, multicenter, non-randomized, single-arm study to evaluate the performance, safety, and efficacy of the GORE® VIABAHN® FORTEGRA Venous Stent (formerly known as GORE® VIAFORT Vascular Stent) for treatment of symptomatic inferior vena cava obstruction with or without combin...
What is the current status of trial NCT05409976?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 112 participants. The study started on 2022-10-25. Estimated completion is 2030-05.
What conditions does trial NCT05409976 study?
This clinical trial studies the following conditions: Venous Leg Ulcer, Venous Ulcer, Venous Stasis, Venous Disease, Venous Occlusion.
What interventions are being tested in trial NCT05409976?
The interventions under investigation include: GORE® VIAFORT Vascular Stent (DEVICE).
Who is sponsoring clinical trial NCT05409976?
This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05409976 being conducted?
This trial has 17 study locations across California, District of Columbia, Illinois, Michigan, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Venous Leg Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
Human Amniotic Membrane On Venous Leg Ulcers In an Elderly Population
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Real World Evidence with the Debritom+ TM Novel Micro Water Jet Technology At a Single Wound Center
RECRUITING · NA
-
INNOVEN: Efficacy of Porcine Placental Extracellular Matrix Plus Standard of Care (SOC) Versus SOC Alone
RECRUITING · NA
-
A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.